Corrigendum: Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol

Affiliations

¹ Neonatal Research Group, Health Research Institute La Fe, University and Polytechnic Hospital La Fe, Valencia, Spain.
² Division of Neonatology, University and Polytechnic Hospital La Fe, Valencia, Spain.
³ Division of Pharmacy, University and Polytechnic Hospital La Fe, Valencia, Spain.
⁴ Division of Neonatology, Regional University Hospital of Malaga, Málaga, Spain.
⁵ Division of Neonatology, University Hospital Reina Sofía, Córdoba, Spain.

Published Erratum

Ana García-Robles et al. Front Pediatr. 2022.

. 2022 Jan 13:9:834454.

doi: 10.3389/fped.2021.834454. eCollection 2021.

¹ Neonatal Research Group, Health Research Institute La Fe, University and Polytechnic Hospital La Fe, Valencia, Spain.
² Division of Neonatology, University and Polytechnic Hospital La Fe, Valencia, Spain.
³ Division of Pharmacy, University and Polytechnic Hospital La Fe, Valencia, Spain.
⁴ Division of Neonatology, Regional University Hospital of Malaga, Málaga, Spain.
⁵ Division of Neonatology, University Hospital Reina Sofía, Córdoba, Spain.

Abstract

[This corrects the article DOI: 10.3389/fped.2020.00372.].

Keywords: ductus; efficacy; paracetamol; pharmacogenetics; pharmacokinetics; safety.

Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol.
García-Robles A, Gimeno Navarro A, Serrano Martín MDM, Párraga Quiles MJ, Parra Llorca A, Poveda-Andrés JL, Vento Torres M, Aguar Carrascosa M. García-Robles A, et al. Front Pediatr. 2020 Jul 17;8:372. doi: 10.3389/fped.2020.00372. eCollection 2020. Front Pediatr. 2020. PMID: 32766181 Free PMC article.